title: Cross-boundary cancer studies at the University of Tokyo: Opening a path through research to the future of cancer treatment.
authors: please contact Hideyuki Akaza, MD, Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan. akazah@med.rcast.u-tokyo.ac.jp.
authors: Tetsuo
authors: T
authors: Noda
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000494:pharmacology; D035843:Biomedical Research / Q000458:organization & administration / Q000639:trends*; D002986:Clinical Trials as Topic / Q000639:trends*; D015195:Drug Design; D055808:Drug Discovery; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D007564:Japan; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D009858:Oncogenic Viruses; D014481:United States
chemical_list: D000970:Antineoplastic Agents
keywords: Cross-boundary Cancer Studies; Japan; cancer treatment; drug development; the University of Tokyo